JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 9 January 2009

Journal of Molecular Endocrinology 2009;42:291.

Journal of Molecular Endocrinology (2009) In press  DOI: 10.1677/JME-08-0107
© 2009 Society for Endocrinology

This Article
Right arrow Accepted manuscript (PDF)
Right arrow Supplementary Tables
Right arrow All Versions of this Article:
JME-08-0107v1
42/4/291    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abel, M.
Right arrow Articles by O'Shaughnessy, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abel, M.
Right arrow Articles by O'Shaughnessy, P.

Research

Effects of follicle stimulating hormone on testicular mRNA transcript levels in the hypogonadal mouse

Margaret Abel, Dilair Baban, Sheena Lee, Harry Charlton and Peter O'Shaughnessy

M Abel, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom
D Baban, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
S Lee, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom
H Charlton, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom
P O'Shaughnessy, Division of Cell Sciences, Institute of Comparative Medicine, University of Glasgow Veterinary School, Bearsden Rd., Glasgow G61 1QH Scotland, U.K, University of Glasgow, Glasgow, G61 1QH, United Kingdom

Correspondence: Peter O'Shaughnessy, Email: P.J.OShaughnessy{at}vet.gla.ac.uk

Abstract

Follicle stimulating hormone (FSH) acts through the Sertoli cell to ensure normal testicular development and function. To identify transcriptional mechanisms through which FSH acts in the testis we have treated gonadotrophin-deficient hypogonadal (hpg) mice with recombinant FSH and measured changes in testicular transcript levels using microarrays and real-time PCR 12, 24 and 72h after the start of treatment. Approximately 400 transcripts were significantly altered at each time point by FSH treatment. At 12h there was a clear increase in the levels of a number of known Sertoli cell transcripts (eg Fabp5, Lgals1, Tesc, Scara5, Aqp5). Additionally, levels of Leydig cell transcipts were also markedly increased (eg Ren1, Cyp17a1, Akr1b7, Star, Nr4a1). This was associated with a small but significant rise in testosterone at 24 and 72h. At 24h, androgen-dependent Sertoli cell transcripts were upregulated (eg Rhox5, Drd4, Spinlw1, Tubb3 and Tsx) and this trend continued up to 72h. In contrast to the somatic cells, only 5 germ cell trancripts (Dkkl1, Hdc, Oct4, Zfp541 and 1700021K02Rik) were altered by FSH within the time-course of the experiment. Analysis of canonical pathways showed that FSH induced a general decline in transcripts related to formation and regulation of tight junctions . Results show FSH acts directly and indirectly to induce rapid changes in Sertoli cell and Leydig cell transcript levels in the hpg mouse but that effects on germ cell development must occur over a longer time span.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Society for Endocrinology.